Target intelligence / Profile preview

Vaginal pH and local metabolite environment

Molecular classification
Other
01

Overview

The vaginal pH and local metabolite environment constitute a dynamic physiological milieu essential for maintaining reproductive health and preventing infection. In healthy individuals of reproductive age, the vaginal pH is typically acidic, ranging from 3.8 to 4.5, a state primarily maintained by Lactobacillus species that ferment glycogen-derived glucose into lactic acid (StatPearls, 2023). This acidic environment, along with metabolites such as hydrogen peroxide and bacteriocins, serves as a primary innate immune barrier against the overgrowth of pathogenic bacteria and the acquisition of sexually transmitted infections (Amabebe & Anumba, 2018). When this balance is disrupted—a condition known as dysbiosis—the pH rises, and the metabolite profile shifts toward increased concentrations of biogenic amines and short-chain fatty acids, which are associated with bacterial vaginosis and adverse pregnancy outcomes (Borgdorff et al., 2016). Therapeutic strategies targeting this environment include the use of pH-buffering gels, such as Phexxi, and vaginal acidifiers like boric acid to restore the natural acidity (FDA, 2020). Additionally, probiotics and metabolic precursors are being explored to promote a stable, Lactobacillus-dominant environment as a preventative and curative measure for vaginal dysbiosis.

Other names
Vaginal microenvironmentVaginal milieuVaginal acid-base balanceVaginal metabolomeVaginal ecosystem
02

Mechanism of action

Restoration and maintenance of an acidic vaginal pH (3.5–4.5) to inhibit pathogen proliferation and support commensal microbial dominance through the delivery of exogenous acids or buffering agents (StatPearls, 2023; FDA, 2020).

03

Biological functions

Innate immunityMicrobial homeostasisBarrier functionMetabolismReproductive health
04

Disease associations

InfectionBacterial vaginosisVulvovaginal candidiasisSexually transmitted infectionsPreterm birthPelvic inflammatory disease
05

Safety considerations

Local irritationVulvovaginal burningDisruption of natural commensal floraPotential for systemic absorption of topical agentsRisk of secondary yeast infections (Vulvovaginal candidiasis)
06

Interacting drugs

Lactic acid

6 more in the full profile.

07

Biomarkers

Vaginal pH levelLactic acid concentrationBiogenic amines (e.g., putrescine, cadaverine)Nugent scoreLactobacillus abundanceShort-chain fatty acids (SCFAs)

Beyond the preview

Go deeper on Vaginal pH and local metabolite environment.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Vaginal pH and local metabolite environment.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call